Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-15 Sale | 2026-06-17 6:38 pm | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 1,624 | $3.05 | $4,953 | 295,324 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 6:41 pm | CytomX Therapeutics Inc. | CTMX | Chu Yu-Waye Chief Medical Officer | 21,279 | $6.423 | $136,675 | 189,446 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 6:35 pm | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 118,969 | $6.423 | $764,138 | 1,172,080 (Indirect Direct) | View |
| 2026-03-17 Sale | 2026-03-19 6:25 pm | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 31,492 | $6.423 | $202,273 | 300,760 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 6:21 pm | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 19,323 | $6.423 | $124,112 | 296,948 (Direct) | View |
| 2025-11-06 Sale | 2025-11-10 4:05 pm | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 101,793 | $4.5377 | $461,906 | 1,081,049 (Indirect Direct) | View |
| 2025-06-13 Sale | 2025-06-17 4:11 pm | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 12,255 | $2.7239 | $33,381 | 226,271 (Direct) | View |
| 2025-06-16 Sale | 2025-06-17 4:10 pm | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 13,884 | $2.689 | $37,334 | 272,252 (Direct) | View |
| 2025-06-16 Sale | 2025-06-17 4:09 pm | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 55,511 | $2.6889 | $149,264 | 1,182,842 (Indirect Direct) | View |
| 2025-03-18 Sale | 2025-03-20 4:34 pm | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 37,656 | $0.599 | $22,556 | 1,088,353 (Indirect Direct) | View |
| 2025-03-18 Sale | 2025-03-20 4:33 pm | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 8,551 | $0.599 | $5,122 | 201,026 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-03 Option Award | 2026-08-05 7:33 pm | N/A 2036-08-02 | CytomX Therapeutics Inc. | CTMX | Carvajal Alejandra Chief Legal Officer | 550,000 | $0 | 550,000 (Direct) | View |
| 2026-07-24 Option Award | 2026-07-30 5:07 pm | N/A 2036-07-23 | CytomX Therapeutics Inc. | CTMX | Fuchs Charles S. Director | 118,000 | $0 | 118,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:53 pm | N/A 2036-06-16 | CytomX Therapeutics Inc. | CTMX | Su Zhen Director | 59,000 | $0 | 59,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:52 pm | N/A 2036-06-16 | CytomX Therapeutics Inc. | CTMX | Young Matthew P. Director | 59,000 | $0 | 59,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:50 pm | N/A 2036-06-16 | CytomX Therapeutics Inc. | CTMX | Mohindru Mani Director | 59,000 | $0 | 59,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:49 pm | N/A 2036-06-16 | CytomX Therapeutics Inc. | CTMX | Meyers James R Director | 59,000 | $0 | 59,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:48 pm | N/A 2036-06-16 | CytomX Therapeutics Inc. | CTMX | Gilbert Halley E Director | 59,000 | $0 | 59,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:47 pm | N/A 2036-06-16 | CytomX Therapeutics Inc. | CTMX | Ashworth Alan Director | 59,000 | $0 | 59,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:45 pm | N/A 2036-06-16 | CytomX Therapeutics Inc. | CTMX | Jones Elaine V Director | 59,000 | $0 | 59,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:28 pm | N/A 2036-02-01 | CytomX Therapeutics Inc. | CTMX | Lester Rachael Chief Business Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:27 pm | N/A 2036-02-01 | CytomX Therapeutics Inc. | CTMX | Chu Yu-Waye Chief Medical Officer | 375,000 | $0 | 510,725 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:25 pm | N/A 2036-02-01 | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 310,000 | $0 | 582,252 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:23 pm | N/A 2036-02-01 | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 415,000 | $0 | 641,271 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:22 pm | N/A 2036-02-01 | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 1,190,000 | $0 | 2,271,049 (Direct) | View |
| 2025-10-20 Option Award | 2025-10-29 4:50 pm | N/A 2035-10-19 | CytomX Therapeutics Inc. | CTMX | Lester Rachael Chief Business Officer | 650,000 | $0 | 650,000 (Direct) | View |
| 2025-09-26 Option Award | 2025-09-30 6:40 pm | N/A 2035-09-25 | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 855,000 | $0 | 855,000 (Direct) | View |
| 2025-09-26 Option Award | 2025-09-30 6:39 pm | N/A 2035-09-25 | CytomX Therapeutics Inc. | CTMX | Chu Yu-Waye Chief Medical Officer | 131,250 | $0 | 131,250 (Direct) | View |
| 2025-09-26 Option Award | 2025-09-30 6:38 pm | N/A 2035-09-25 | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 117,400 | $0 | 117,400 (Direct) | View |
| 2025-09-26 Option Award | 2025-09-30 6:37 pm | N/A 2035-09-25 | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 54,450 | $0 | 54,450 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-17 4:11 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 37,500 | $0 | 226,271 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-17 4:10 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 37,500 | $0 | 272,252 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-17 4:09 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 150,000 | $0 | 1,182,842 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:19 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Su Zhen Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:18 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Young Matthew P. Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:18 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Mohindru Mani Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:17 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Meyers James R Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:17 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Jones Elaine V Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:16 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Gilbert Halley E Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:16 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Ashworth Alan Director | 38,000 | $0 | 38,000 (Direct) | View |